journal article Jan 01, 2020

Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid

Human Gene Therapy Vol. 31 No. 1-2 pp. 80-89 · SAGE Publications
View at Publisher Save 10.1089/hum.2019.144
Topics

No keywords indexed for this article. Browse by subject →

References
26
[1]
Adeno-associated virus vector as a platform for gene therapy delivery

Dan Wang, Phillip W. L. Tai, Guangping Gao

Nature Reviews Drug Discovery 10.1038/s41573-019-0012-9
[4]
In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous

Deniz Dalkara, Leah C. Byrne, Ryan R. Klimczak et al.

Science Translational Medicine 10.1126/scitranslmed.3005708
[9]
Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration

Timothy K MacLachlan, Michael Lukason, Margaret Collins et al.

Molecular Therapy 10.1038/mt.2010.258
[25]
AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye

Felix F. Reichel, Daniyar L. Dauletbekov, Reinhild Klein et al.

Molecular Therapy 10.1016/j.ymthe.2017.08.018
Cited By
73
Molecular Therapy - Methods & C...
Metrics
73
Citations
26
References
Details
Published
Jan 01, 2020
Vol/Issue
31(1-2)
Pages
80-89
License
View
Cite This Article
Adrian M. Timmers, Judith A. Newmark, Heikki T. Turunen, et al. (2020). Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid. Human Gene Therapy, 31(1-2), 80-89. https://doi.org/10.1089/hum.2019.144